Bristol Myers Squibb today announced that the company will present at J.P. Morgan's 44th Annual Healthcare Conference on Monday, January 12, 2026. The company's presentation and participation in a ...

Helping engineering teams overcome integration, durability, and safety hurdles in harsh environments By Paulius Juskevicius, ...

In a world of constant change, certain individuals do not merely adapt — they lead. These architects of the future are ...

Nusrat Fateh Ali Khan's poignant ghazal-qawwali unexpectedly mirrors the trajectory of the Indian Left, capturing its initial ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Innocan Pharma Corporation (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, today announced that it anticipates ...

President Donald Trump has locked in a sweeping set of pricing agreements with nine of the world's biggest drugmakers, promising to pull some of the most expensive medicines on the U.S. market closer ...

Scroll down for hints and conversation about the puzzle for Sunday, Jan. 4, 2026. By New York Times Games Scroll down for hints and conversation about the puzzle for Saturday, Jan. 3, 2026. By New ...